
Wellcon Canimet 60mg Tablet (Maropitant) for Dogs
This higher-strength formulation of the NK1 receptor antagonist provides 24-hour vomiting prevention by blocking emetic centers in the brain and chemoreceptor trigger zone, offering superior efficacy over metoclopramide or ondansetron for refractory cases in veterinary practice.
- Composition : Maropitant citrate equivalent to 60 mg of maropitant
Indications :
- Acute vomiting prevention/treatment in hospitalized patients.
- Chemotherapy-induced nausea and vomiting (CINV).
- Severe motion sickness during prolonged travel.
- Parvovirus or post-surgical emesis control.
Features :
- Full 24-hour coverage with single daily dosing.
- Targets multiple vomiting pathways simultaneously.
- Minimal sedation compared to phenothiazines.
- Safe for multi-day therapy in critical care.
Directions for Use:
-
Dosage: Dogs >30kg: 2 mg/kg once daily (1 tab/30kg); max 5 consecutive days.
-
Administer 1-2 hours prior to trigger (chemo/travel); with small meal for motion sickness.
-
Veterinary prescription required; avoid in puppies <8 weeks or GI obstruction.
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
Original: $10.99
-65%$10.99
$3.85Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
This higher-strength formulation of the NK1 receptor antagonist provides 24-hour vomiting prevention by blocking emetic centers in the brain and chemoreceptor trigger zone, offering superior efficacy over metoclopramide or ondansetron for refractory cases in veterinary practice.
- Composition : Maropitant citrate equivalent to 60 mg of maropitant
Indications :
- Acute vomiting prevention/treatment in hospitalized patients.
- Chemotherapy-induced nausea and vomiting (CINV).
- Severe motion sickness during prolonged travel.
- Parvovirus or post-surgical emesis control.
Features :
- Full 24-hour coverage with single daily dosing.
- Targets multiple vomiting pathways simultaneously.
- Minimal sedation compared to phenothiazines.
- Safe for multi-day therapy in critical care.
Directions for Use:
-
Dosage: Dogs >30kg: 2 mg/kg once daily (1 tab/30kg); max 5 consecutive days.
-
Administer 1-2 hours prior to trigger (chemo/travel); with small meal for motion sickness.
-
Veterinary prescription required; avoid in puppies <8 weeks or GI obstruction.
Disclosure:
A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.
Disclaimer:
Supertails' sole intention is to ensure that its consumers get information that is expert-reviewed, accurate, and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.





















